Bianca Lederer
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
Papers in
- Oncology 22
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 7
-
- Breast Cancer Treatment Studies 19
- Cancer Genomics and Diagnostics 6
- Co-authors
- Sibylle Loibl (26 shared papers)Carsten Denkert (21 shared papers)Gϋnter von Minckwitz (17 shared papers)Jens‐Uwe Blohmer (13 shared papers)Michael Untch (19 shared papers)Jens Huober (13 shared papers)Sherko Kümmel (10 shared papers)Bernd Gerber (5 shared papers)
- Journals
- Annals of Oncology (3 papers)Breast Cancer Research and Treatment (3 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Bianca Lederer
38 papers receiving 633 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 348
- Oncology 415
- Pathology and Forensic Medicine 147
- Pulmonary and Respiratory Medicine 119
- Radiology, Nuclear Medicine and Imaging 64
Countries citing papers authored by Bianca Lederer
This map shows the geographic impact of Bianca Lederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bianca Lederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bianca Lederer more than expected).
Fields of papers citing papers by Bianca Lederer
This network shows the impact of papers produced by Bianca Lederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bianca Lederer. The network helps show where Bianca Lederer may publish in the future.
Co-authors
The 25 scholars most cited alongside Bianca Lederer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 78 | |
| 2 | 2015 | 77 | |
| 3 | 2014 | 66 | |
| 4 | 2016 | 48 | |
| 5 | 2014 | 47 | |
| 6 | 2014 | 42 | |
| 7 | 2015 | 41 | |
| 8 | 2016 | 34 | |
| 9 | 2020 | 33 | |
| 10 | 2018 | 29 | |
| 11 | 2017 | 21 | |
| 12 | 2023 | 20 | |
| 13 | 2014 | 17 | |
| 14 | 2015 | 10 | |
| 15 | 2019 | 10 | |
| 16 | 2017 | 9 | |
| 17 | 2021 | 8 | |
| 18 | 2016 | 5 | |
| 19 | 2017 | 5 | |
| 20 | [Malignant lymphoma following two years' of immunosuppressive therapy for periarteritis nodosa]. | 1973 | 5 |
About Bianca Lederer
Bianca Lederer is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 39 papers that have together received 646 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (9 papers), Breast Lesions and Carcinomas (8 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Genomics and Diagnostics (6 papers), Advanced Breast Cancer Therapies (4 papers), Estrogen and related hormone effects (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Cancer Research (348 citations), Oncology (415 citations), Pathology and Forensic Medicine (147 citations), Pulmonary and Respiratory Medicine (119 citations) and Radiology, Nuclear Medicine and Imaging (64 citations). Bianca Lederer has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Sibylle Loibl, Carsten Denkert, Gϋnter von Minckwitz, Jens‐Uwe Blohmer, Michael Untch, Jens Huober, Sherko Kümmel, Bernd Gerber, Andreas Schneeweiß and Claus Hanusch. Their work appears in journals such as Annals of Oncology, Breast Cancer Research and Treatment, Cancer Research, Clinical Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.